Stem Cell Therapies

This channel includes news and new technology innovations about cardiac and peripheral vascular stem cell and gene therapies.

ProxiCor Extracellular Matrix Reduces Complications, Readmissions Following Pericardial Reconstruction
News | Stem Cell Therapies | April 19, 2019

April 19, 2019 — Aziyo Biologics Inc. announced the publication of results from its landmark RECON study in the...

FDA Releases Final Guidances on Regenerative Medicine Therapies
News | Stem Cell Therapies | March 04, 2019

March 4, 2019 — The U.S. Food and Drug Administration (FDA) recently finalized two guidance documents regarding...

Heart Muscle Cells Created From Stem Cells Beat in Sync
News | Stem Cell Therapies | February 01, 2019

February 1, 2019 — A team of Rutgers scientists have taken an important step toward the goal of making diseased...

FDA Clamps Down on Unapproved Stem Cell Therapies
News | Stem Cell Therapies | December 20, 2018

December 20, 2018 — The U.S. Food and Drug Administration (FDA) has...

NHLBI Pauses CONCERT-HF Heart Failure Trial
News | Heart Failure | October 29, 2018

October 29, 2018 — The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health...

One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon Stertzer, M.D. In this article he shares his views on the current direction and next steps in cardiovascular biomedical technology

Simon Stertzer, M.D., is one of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s and 1980s. He performed the first coronary balloon angioplasty in the United States in 1978.

 

Feature | October 03, 2018

One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was...

Stem Cell Therapy May Offer Treatment for Rare Congenital Cardiac Defect
News | Congenital Heart | February 05, 2018

February 5, 2018 — Children's Hospital Los Angeles announced participation in the first-ever...

Humanetics Presents Data on Drug to Protect Cardiac Cells From Space-Like Radiation

Photo from NASA

News | Pharmaceuticals | February 01, 2018

February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the...

Secant Introduces First Synthetic Regenerative Cardiovascular Graft for CABG
News | Stem Cell Therapies | January 17, 2018

January 17, 2018 — Secant Group, in partnership with its sister company SanaVita Medical, announced new technology...

News | Stem Cell Therapies | October 24, 2017

October 24, 2017 — Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate...

BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies | September 26, 2017

September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT...

CardiAMP Heart Failure Trial Design Presented at Texas Heart Institute Symposium
News | Heart Failure | September 25, 2017

September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure...

BioCardia Completes Roll-in Cohort in Pivotal Phase III CardiAMP Heart Failure Trial
News | Stem Cell Therapies | August 16, 2017

August 16, 2017 — BioCardia Inc. recently announced completion of treatment for the 10-patient roll-in cohort for...

New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies | August 04, 2017

August 4, 2017 — In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is...

SanBio Receives $20 Million Grant for Stroke Clinical Trial
News | Stroke | July 12, 2017

July 12, 2017 — SanBio Inc. recently announced it has been awarded a $20 million grant from the California Institute...

Overlay Init